Search Results

Filter
  • 1-10 of  941 results for ""MALARIA vaccines""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Naturally acquired IgG responses to Plasmodium falciparum do not target the conserved termini of the malaria vaccine candidate Merozoite Surface Protein 2.

  • Authors : Zerebinski J; Division of Infectious Diseases, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Subjects: Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/immunology ; Immunoglobulin G*/Immunoglobulin G*/Immunoglobulin G*/immunology ; Immunoglobulin G*/Immunoglobulin G*/Immunoglobulin G*/blood

  • Source: Frontiers in immunology [Front Immunol] 2024 Dec 09; Vol. 15, pp. 1501700. Date of Electronic Publication: 2024 Dec 09 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Estimation of PfRh5-based vaccine efficacy in asymptomatic Plasmodium falciparum patients from high-endemic areas of Tanzania using genetic and antigenicity variation screening.

  • Authors : Jun H; Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Republic of Korea.; Mazigo E

Subjects: Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/immunology ; Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/genetics ; Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/immunology

  • Source: Frontiers in immunology [Front Immunol] 2024 Nov 18; Vol. 15, pp. 1495513. Date of Electronic Publication: 2024 Nov 18 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

RH5: rationally-designed malaria vaccine antigen improving efficacy.

  • Authors : Takashima E; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan.; Tsuboi T

Subjects: Antigens, Protozoan*/Antigens, Protozoan*/Antigens, Protozoan*/immunology ; Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/immunology ; Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/prevention & control

  • Source: Trends in parasitology [Trends Parasitol] 2024 Oct; Vol. 40 (10), pp. 870-872. Date of Electronic Publication: 2024 Sep 13.Publisher: Elsevier Science Country of Publication: England NLM ID: 100966034 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.

  • Authors : Barrett JR; Department of Biochemistry, University of Oxford, Oxford OX1 3QU, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford OX1 3QU, UK

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/immunology ; Antibodies, Protozoan*/Antibodies, Protozoan*/Antibodies, Protozoan*/immunology ; Antigens, Protozoan*/Antigens, Protozoan*/Antigens, Protozoan*/immunology

  • Source: Cell [Cell] 2024 Sep 05; Vol. 187 (18), pp. 4964-4980.e21. Date of Electronic Publication: 2024 Jul 25.Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5.

  • Authors : Wang LT; Antibody Biology Unit, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA

Subjects: Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology ; Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/immunology ; Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/immunology

  • Source: Cell [Cell] 2024 Sep 05; Vol. 187 (18), pp. 4981-4995.e14. Date of Electronic Publication: 2024 Jul 25.Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Structure-based design of a Plasmodium vivax Duffy-binding protein immunogen focuses the antibody response to functional epitopes.

  • Authors : Dickey TH; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, USA.; McAleese H

Subjects: Protozoan Proteins*/Protozoan Proteins*/Protozoan Proteins*/immunology ; Protozoan Proteins*/Protozoan Proteins*/Protozoan Proteins*/chemistry ; Protozoan Proteins*/Protozoan Proteins*/Protozoan Proteins*/genetics

  • Source: Protein science : a publication of the Protein Society [Protein Sci] 2024 Aug; Vol. 33 (8), pp. e5095.Publisher: Cold Spring Harbor Laboratory Press Country of Publication: United States NLM ID: 9211750 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Exploring the genetic diversity pattern of PvEBP/DBP2: A promising candidate for an effective Plasmodium vivax vaccine.

  • Authors : Hernández-Zambrano LJ; Grupo de Estudios en Genética y Biología Molecular (GEBIMOL), School of Biological Sciences, Universidad Pedagógica y Tecnológica de Colombia - UPTC, Tunja, Boyacá, Colombia; Population Genetics And Molecular Evolution (PGAME), Fundación Scient, Tunja, Boyacá, Colombia.

Subjects: Plasmodium vivax*/Plasmodium vivax*/Plasmodium vivax*/genetics ; Plasmodium vivax*/Plasmodium vivax*/Plasmodium vivax*/immunology ; Genetic Variation*

  • Source: Acta tropica [Acta Trop] 2024 Jul; Vol. 255, pp. 107231. Date of Electronic Publication: 2024 Apr 27.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0370374 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex.

  • Authors : Williams BG; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.; Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, UK.

Subjects: Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/immunology ; Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/administration & dosage ; Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/immunology

  • Source: Nature communications [Nat Commun] 2024 Jun 07; Vol. 15 (1), pp. 4857. Date of Electronic Publication: 2024 Jun 07.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Diversity and selection analyses identify transmission-blocking antigens as the optimal vaccine candidates in Plasmodium falciparum.

  • Authors : Ciubotariu II; Department of Biological Sciences, Purdue University, West Lafayette, IN, USA.; Broyles BK

Subjects: Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/immunology ; Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/genetics ; Malaria Vaccines*/Malaria Vaccines*/Malaria Vaccines*/immunology

  • Source: EBioMedicine [EBioMedicine] 2024 Aug; Vol. 106, pp. 105227. Date of Electronic Publication: 2024 Jul 16.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of Plasmodium vivax in murine model.

  • Authors : Matos ADS; Immunoparasitology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.; Soares IF

Subjects: Plasmodium vivax*/Plasmodium vivax*/Plasmodium vivax*/immunology ; Plasmodium vivax*/Plasmodium vivax*/Plasmodium vivax*/genetics ; Antigens, Protozoan*/Antigens, Protozoan*/Antigens, Protozoan*/immunology

  • Source: Frontiers in immunology [Front Immunol] 2024 Jun 19; Vol. 15, pp. 1392043. Date of Electronic Publication: 2024 Jun 19 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
  • 1-10 of  941 results for ""MALARIA vaccines""